vertex pain management - Search News

Vertex Stock Jumps

CNBC on MSN · 20h

FDA approves Vertex’s non-opioid painkiller, first new kind of pain medicine in decades

The Food and Drug Administration approved Vertex Pharmaceuticals' non-opioid painkiller pill, a new alternative for pain relief that comes without the risk of addiction. It's a milestone after a long history of unsuccessful efforts to develop painkillers without the destructive dependency of opioids,

Seeking Alpha · 1h

Vertex Pharma Stock Surges After FDA Approves Non-Opioid Pain Drug

Analyst is bullish on Vertex Pharmaceuticals, citing FDA approval for JOURNAVX and strong earnings growth potential in 2025.

BioPharma Dive · 20h

Vertex’s non-opioid pain drug gets FDA approval in milestone for company and research

Despite high demand for an option like Journavx, doctors fear the drug’s price could be a major hangup for insurers, potentially limiting patients’ ability to access it.

BioPharma Dive2h

A new, non-opioid pain drug is here. Getting it to patients could be agony.

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

4h

Vertex Pharmaceuticals Shares Are Up Today: What's Going On?

Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) shares are trading higher Friday following two major developments that strengthen ...

3d

Vertex Pharmaceuticals’ Suzetrigine: A Promising Opioid Alternative in Pain Management

Leerink Partners analyst David Risinger has reiterated their bullish stance on VRTX stock, giving a Buy rating yesterday.Invest with ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results